Wave Life Sciences (WVE) Receivables (2014 - 2025)

Wave Life Sciences' Receivables history runs 10 years deep, the most recent figure standing at $1.3 million for Q4 2025.

• Quarterly Receivables fell 10.27% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (down 10.27% YoY) and the FY2025 annual result came in at $1.3 million, down 10.27% from the prior year.
• Receivables was $1.3 million for Q4 2025 at Wave Life Sciences, down from $10.0 million in the prior quarter.
• Across five years, Receivables topped out at $30.0 million in Q1 2021 and bottomed at $1.3 million in Q4 2025.
• A 4-year average of $10.7 million and a median of $7.0 million in 2023 frame the typical range for Receivables.
• Annual changes were most pronounced in 2024 — Receivables sank 93.26% — and 2025, when it increased 25.35%.
• Wave Life Sciences' Receivables stood at $22.5 million in 2021, then slipped by 6.28% to $21.1 million in 2023, then sank by 93.26% to $1.4 million in 2024, then declined by 10.27% to $1.3 million in 2025.
• Business Quant data shows WVE's Receivables at $1.3 million in Q4 2025, $10.0 million in Q3 2025, and $1.6 million in Q2 2025.